Lynne Chou O'Keefe - 15 Dec 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
15 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 15:41:43 UTC
Previous filing
21 Sep 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +10,044 10,044 15 Dec 2022 Direct F1
holding HIMS Class A Common Stock 157,874 15 Dec 2022 Held by Define Ventures Fund I, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -18 -11% $0.000000 142 15 Dec 2022 Class A Common Stock 18 Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -893 -11% $0.000000 7,148 15 Dec 2022 Class A Common Stock 893 Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -9,133 -11% $0.000000 73,069 15 Dec 2022 Class A Common Stock 9,133 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 Ms. Chou O'Keefe may be deemed a beneficial owner of the securities held by Define Ventures Fund I, L.P..
F3 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company.